News

Jun 26
Second Employers’ Liability, Public Liability and Commercial Property Insurance Report of the NCID published

Report provides key statistics on employers’ liability, public liability, and commercial property insurance in Ireland; including data on claims costs and settlement channels. On average, employers’ liability and public liability claims settled through litigation cost more and take longer to settle than claims settled directly or via the PIAB. Insurers’ income and expenditure on Employers’ […]

Jun 26
Central Bank contacts business groups regarding Financial Sanctions obligations

The adoption of sanctions places legally binding obligations on all individuals and entities The Central Bank is sharing information with business representatives regarding individual and firm-level obligations Sanctions breaches must be reported to An Garda Siochana Against the backdrop of Russia’s invasion of Ukraine and the introduction of EU Regulations relating to financial sanctions, the […]

Jun 26
Central Bank calls on firms to prevent IBAN discrimination

IBAN discrimination is an issue across Europe as more firms offer financial services cross border The Central Bank has contacted regulated firms and business representative bodies in Ireland to reinforce all organisations’ responsibilities under SEPA Supporting consumer choice to choose a provider with a non-Irish IBAN is important as Ulster Bank and KBC exit the […]

Jun 26
Biogen stops clinical trial tracking Aduhelm

Biogen Inc. BIIB, +0.26% said in a statement that it stopped a post-marketing clinical trial testing its Alzheimer’s disease therapy Aduhelm, citing a Medicare policy that will limit usage of the drug. The company updated the study’s ClinicalTrials.gov listing with this information on Tuesday. The prospective, multi-center study planned to track patients taking Aduhelm for […]

Jun 25
Sanofi, GSK say their next-generation COVID-19 booster has 72% efficacy against omicron

Sanofi SNY, +5.95% SAN, +5.02% and GlaxoSmithKline GSK, +2.20% said Friday that their experimental bivalent COVID-19 booster had a 72% efficacy rate against omicron, and they now plan to submit the data to regulators. The recombinant protein booster protects against the original strain of the virus as well as the beta variant, a strain of […]

Jun 25
FTX may be planning to purchase a stake in BlockFi: Report

Reportedly, ongoing talks followed BlockFi signing a term sheet with FTX to secure a $250 million revolving credit facility on Tuesday. 1831 Total views 44 Total shares Crypto exchange FTX is reportedly in talks to acquire a stake in BlockFi after the company issued a $250 million credit to the lending firm. According to a […]